Martin Shkreli refuses to answer questions in Congress
Martin Shkreli, former head of Turing Pharmaceuticals, refused to answer questions at a congressional hearing focused on the company's drug pricing policy.
He invoked his constitutional right against self-incrimination.
Congress is investigating Turing's 5,000% price increase of a drug, Daraprim, used by many Aids patients.
04 Feb 2016
- From the section Business